Pemetrexed (MTA) compared with erlotinib (ERL) in pretreated patients with advanced non-small cell lung cancer (NSCLC): Results of a randomized phase III Hellenic Oncology Research Group trial.
2010 ◽
Vol 28
(15_suppl)
◽
pp. 7519-7519
◽
Keyword(s):
2010 ◽
Vol 28
(15_suppl)
◽
pp. 7605-7605
◽
Keyword(s):
Keyword(s):
2017 ◽
Vol 8
(1)
◽
pp. 23-30
◽
Keyword(s):